Pfizer vaccine significantly less effective in kids 5-11: study

The Pfizer coronavirus vaccine is significantly less effective in children aged 5-11 than it is in older kids, a new study finds, raising questions about the correct dose to give to the young.

The study from researchers at the New York State Department of Health found that vaccine effectiveness against COVID-19 infection among children 5-11 declined from 68 percent to just 12 percent over the period of Dec. 13 to Jan. 30.

Effectiveness was higher for those aged 12-17, declining from 66 percent to 51 percent over the same period.

Children under 12 receive a dose that is one-third the size given to those 12 and up, which could explain the drop in effectiveness.

The study notes that effectiveness for children aged 5-11 was better against severe disease, and that vaccination is still recommended.

The vaccine’s effectiveness against hospitalization among children 5-11 declined from 100 percent to 48 percent, compared to 85 percent to 73 percent for older children.

The results highlight the challenges that vaccination for children have faced. Pfizer earlier this month delayed the timeline for its vaccine for children under 5, saying more time was needed to test a third dose.

The dose being tested in children under 5 is even smaller.

“These results highlight the potential need to study alternative vaccine dosing for children and the continued importance layered protections, including mask wearing, to prevent infection and transmission,” the study states.

Still, the analysis says vaccination of children under 12 should continue, an area where rates have been lagging.

---

Source: The Hill

---